Back to search results

Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa

Abroad (travel likely)RecruitingPHASE2

Conditions

HIV-1-infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Gaborone CRS (12701), Gaborone, Botswana

    Contact: Study coordinator (Unoda Chakalisa) · uchakalisa@bhp.org.bw · (011 267) 393-1353
    Contact: Principal Investigator (Ayotunde Omoz-Oarhe, MD)

  • University of the Witwatersrand Helen Joseph (WITS HJH) CRS (11101), Johannesburg, Gauteng, South Africa

    Contact: Study coordinator (Betty Matome, Dip) · bmatome@witshealth.co.za · 27-11-2768817
    Contact: Principal Investigator (Sharlaa Badal-Faesen, MD, MBBCH)

  • CAPRISA eThekwini CRS (31422), Durban, KwaZulu-Natal, South Africa

    Contact: Study coordinator (Bongekile Zuma, BTech) · Bongi.zuma@caprisa.org · 27-031-655 0658
    Contact: Principal Investigator (Kogieleum Naidoo, MBChB, PhD)

  • Durban Adult HIV CRS (11201), Durban, South Africa

    Contact: Study coordinator (Rosie Mngqibisa, MB, ChB) · mngqibisa@ecarefoundation.com · 27-31-2604469
    Contact: Principal Investigator (Umesh Gangaram Lalloo, MD, FRCP)
Study leads

  • Trevor Crowell, MD, PhD

    Study Chair

    US Military HIV Research Program CTU

  • Wadzanai Samaneka, MBChB, MSc

    Study Chair

    Milton Park CRS

View source on ClinicalTrials.gov(opens in a new tab)